Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -328.85% | -320.81% | 29.32% | 27.67% | 55.71% |
| Total Depreciation and Amortization | 4.30% | 2.23% | -4.49% | -2.16% | -1.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -119.37% | -115.26% | 99.96% | 104.63% | -14.68% |
| Change in Net Operating Assets | 188.02% | 186.37% | -- | -- | -4,305.23% |
| Cash from Operations | 13.61% | 15.23% | 126.79% | 127.41% | -70.82% |
| Capital Expenditure | -418.18% | -409.09% | -60.00% | -60.00% | 71.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -418.18% | -409.09% | -60.00% | -60.00% | 71.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 36.84% | 36.84% | 30.66% | 30.66% | -24.12% |
| Issuance of Common Stock | -100.00% | -100.00% | 22.36% | 22.36% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -16.75% | -16.75% | -- |
| Cash from Financing | -65.82% | -66.46% | 22.85% | 25.72% | 21,020.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.92% | -200.15% | 345.28% | 355.68% | 66.89% |